Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Phase 1 Assessment of the Safety and Immunogenicity of an mRNA- Lipid Nanoparticle Vaccine Candidate Against SARS-CoV-2 in Human Volunteers

Peter Kremsner, Philipp Mann, Jacobus Bosch, Rolf Fendel, Julian J. Gabor, Andrea Kreidenweiss, Arne Kroidl, Isabel Leroux-Roels, Geert Leroux-Roels, Christoph Schindler, Mirjam Schunk, Thirumalaisamy P. Velavan, Mariola Fotin-Mleczek, Stefan Müller, Gianluca Quintini, Oliver Schönborn-Kellenberger, Dominik Vahrenhorst, Thomas Verstraeten, Lisa Walz, Olaf-Oliver Wolz, Lidia Oostvogels
doi: https://doi.org/10.1101/2020.11.09.20228551
Peter Kremsner
1Institute of Tropical Medicine, University Hospital Tübingen, Tübingen, Germany
10German Center for Infection Research (DZIF), partner site Tübingen, Tübingen, Germany
11Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philipp Mann
6Curevac AG, Frankfurt, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jacobus Bosch
5Hannover Medical School (MHH), Hannover, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rolf Fendel
1Institute of Tropical Medicine, University Hospital Tübingen, Tübingen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julian J. Gabor
1Institute of Tropical Medicine, University Hospital Tübingen, Tübingen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Kreidenweiss
1Institute of Tropical Medicine, University Hospital Tübingen, Tübingen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arne Kroidl
3Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Germany
4German Center for Infection Research (DZIF), partner site Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isabel Leroux-Roels
2Ghent University Hospital, Ghent, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Geert Leroux-Roels
2Ghent University Hospital, Ghent, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christoph Schindler
5Hannover Medical School (MHH), Hannover, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mirjam Schunk
3Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Germany
4German Center for Infection Research (DZIF), partner site Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thirumalaisamy P. Velavan
1Institute of Tropical Medicine, University Hospital Tübingen, Tübingen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mariola Fotin-Mleczek
9Curevac AG, Tübingen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefan Müller
6Curevac AG, Frankfurt, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gianluca Quintini
8Cogitars, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oliver Schönborn-Kellenberger
8Cogitars, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dominik Vahrenhorst
9Curevac AG, Tübingen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Verstraeten
7P95 Epidemiology and Pharmacovigilance, Leuven, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lisa Walz
6Curevac AG, Frankfurt, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olaf-Oliver Wolz
9Curevac AG, Tübingen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lidia Oostvogels
6Curevac AG, Frankfurt, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: lidia.oostvogels@curevac.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Data Availability

No additional data are referred to

Back to top
PreviousNext
Posted November 09, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Phase 1 Assessment of the Safety and Immunogenicity of an mRNA- Lipid Nanoparticle Vaccine Candidate Against SARS-CoV-2 in Human Volunteers
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Phase 1 Assessment of the Safety and Immunogenicity of an mRNA- Lipid Nanoparticle Vaccine Candidate Against SARS-CoV-2 in Human Volunteers
Peter Kremsner, Philipp Mann, Jacobus Bosch, Rolf Fendel, Julian J. Gabor, Andrea Kreidenweiss, Arne Kroidl, Isabel Leroux-Roels, Geert Leroux-Roels, Christoph Schindler, Mirjam Schunk, Thirumalaisamy P. Velavan, Mariola Fotin-Mleczek, Stefan Müller, Gianluca Quintini, Oliver Schönborn-Kellenberger, Dominik Vahrenhorst, Thomas Verstraeten, Lisa Walz, Olaf-Oliver Wolz, Lidia Oostvogels
medRxiv 2020.11.09.20228551; doi: https://doi.org/10.1101/2020.11.09.20228551
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Phase 1 Assessment of the Safety and Immunogenicity of an mRNA- Lipid Nanoparticle Vaccine Candidate Against SARS-CoV-2 in Human Volunteers
Peter Kremsner, Philipp Mann, Jacobus Bosch, Rolf Fendel, Julian J. Gabor, Andrea Kreidenweiss, Arne Kroidl, Isabel Leroux-Roels, Geert Leroux-Roels, Christoph Schindler, Mirjam Schunk, Thirumalaisamy P. Velavan, Mariola Fotin-Mleczek, Stefan Müller, Gianluca Quintini, Oliver Schönborn-Kellenberger, Dominik Vahrenhorst, Thomas Verstraeten, Lisa Walz, Olaf-Oliver Wolz, Lidia Oostvogels
medRxiv 2020.11.09.20228551; doi: https://doi.org/10.1101/2020.11.09.20228551

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (168)
  • Anesthesia (50)
  • Cardiovascular Medicine (450)
  • Dentistry and Oral Medicine (82)
  • Dermatology (55)
  • Emergency Medicine (157)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (191)
  • Epidemiology (5248)
  • Forensic Medicine (3)
  • Gastroenterology (195)
  • Genetic and Genomic Medicine (755)
  • Geriatric Medicine (80)
  • Health Economics (212)
  • Health Informatics (696)
  • Health Policy (356)
  • Health Systems and Quality Improvement (223)
  • Hematology (99)
  • HIV/AIDS (162)
  • Infectious Diseases (except HIV/AIDS) (5848)
  • Intensive Care and Critical Care Medicine (358)
  • Medical Education (103)
  • Medical Ethics (25)
  • Nephrology (80)
  • Neurology (762)
  • Nursing (43)
  • Nutrition (130)
  • Obstetrics and Gynecology (141)
  • Occupational and Environmental Health (231)
  • Oncology (476)
  • Ophthalmology (150)
  • Orthopedics (38)
  • Otolaryngology (95)
  • Pain Medicine (39)
  • Palliative Medicine (20)
  • Pathology (140)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (136)
  • Primary Care Research (96)
  • Psychiatry and Clinical Psychology (859)
  • Public and Global Health (2004)
  • Radiology and Imaging (348)
  • Rehabilitation Medicine and Physical Therapy (158)
  • Respiratory Medicine (283)
  • Rheumatology (94)
  • Sexual and Reproductive Health (73)
  • Sports Medicine (76)
  • Surgery (109)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)